1.To compare the symptoms relief over the time among the three treatment group. <br/ >2.To compare the difference in proportion of patients with improved clinical outcome defined by ordinal scale over the time between the treatment groups. <br/ >3.To compare the duration for conversion of Covid-19 positive status to negative between the treatment groups. <br/ > <br/ >Timepoint: 1. Daily assessment of the patient. <br/ >2. At the end of 28 days or discharge of the patient- whichever is earlier.

1.To compare the symptoms relief over the time among the three treatment group. <br/ >2.To compare the difference in proportion of patients with improved clinical outcome defined by ordinal scale over the time between the treatment groups. <br/ >3.To compare the duration for conversion of Covid-19 positive status to negative between the treatment groups. <br/ > <br/ >Timepoint: 1. Daily assessment of the patient. <br/ >2. At the end of 28 days or discharge of the patient- whichever is earlier.

N/A

N/A

1.To compare the symptoms relief over the time among the three treatment group. <br/ >2.To compare the difference in proportion of patients with improved clinical outcome defined by ordinal scale over the time between the treatment groups. <br/ >3.To compare the duration for conversion of Covid-19 positive status to negative between the treatment groups. <br/ > <br/ >Timepoint: 1. Daily assessment of the patient. <br/ >2. At the end of 28 days or discharge of the patient- whichever is earlier.

1.To compare the symptoms relief over the time among the three treatment group. <br/ >2.To compare the difference in proportion of patients with improved clinical outcome defined by ordinal scale over the time between the treatment groups. <br/ >3.To compare the duration for conversion of Covid-19 positive status to negative between the treatment groups. <br/ > <br/ >Timepoint: 1. Daily assessment of the patient. <br/ >2. At the end of 28 days or discharge of the patient- whichever is earlier.